Legal & General Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.2M Buy
40,245
+4,136
+11% +$432K ﹤0.01% 1630
2025
Q1
$4.21M Sell
36,109
-261
-0.7% -$30.4K ﹤0.01% 1606
2024
Q4
$3.08M Buy
36,370
+2,107
+6% +$178K ﹤0.01% 1802
2024
Q3
$3.08M Buy
34,263
+614
+2% +$55.2K ﹤0.01% 1797
2024
Q2
$2.71M Buy
33,649
+782
+2% +$63K ﹤0.01% 1806
2024
Q1
$2.62M Sell
32,867
-150
-0.5% -$12K ﹤0.01% 1810
2023
Q4
$2.63M Sell
33,017
-883
-3% -$70.3K ﹤0.01% 1810
2023
Q3
$2.37M Buy
33,900
+576
+2% +$40.3K ﹤0.01% 1817
2023
Q2
$2.39M Buy
33,324
+2,676
+9% +$192K ﹤0.01% 1838
2023
Q1
$1.89M Buy
30,648
+3,637
+13% +$224K ﹤0.01% 1900
2022
Q4
$2.08M Buy
27,011
+250
+0.9% +$19.3K ﹤0.01% 1867
2022
Q3
$1.19M Sell
26,761
-1,771
-6% -$79K ﹤0.01% 2094
2022
Q2
$1.09M Buy
28,532
+5,987
+27% +$229K ﹤0.01% 2131
2022
Q1
$933K Sell
22,545
-14
-0.1% -$579 ﹤0.01% 2249
2021
Q4
$852K Buy
22,559
+60
+0.3% +$2.27K ﹤0.01% 2274
2021
Q3
$741K Buy
22,499
+4,752
+27% +$157K ﹤0.01% 2319
2021
Q2
$1.2M Sell
17,747
-166
-0.9% -$11.2K ﹤0.01% 2163
2021
Q1
$1.01M Buy
17,913
+2,031
+13% +$115K ﹤0.01% 2190
2020
Q4
$1.29M Sell
15,882
-82
-0.5% -$6.68K ﹤0.01% 2040
2020
Q3
$1.14M Sell
15,964
-1,220
-7% -$86.9K ﹤0.01% 1986
2020
Q2
$1.41M Buy
17,184
+189
+1% +$15.5K ﹤0.01% 1873
2020
Q1
$1M Buy
16,995
+9,068
+114% +$534K ﹤0.01% 1850
2019
Q4
$820K Buy
7,927
+2,691
+51% +$278K ﹤0.01% 2116
2019
Q3
$106K Hold
5,236
﹤0.01% 2500
2019
Q2
$135K Buy
+5,236
New +$135K ﹤0.01% 2441
2017
Q2
Sell
-1,158
Closed -$5K 3358
2017
Q1
$5K Hold
1,158
﹤0.01% 3237
2016
Q4
$8K Buy
+1,158
New +$8K ﹤0.01% 3246